Skip to main content
Equibles

Opaleye Management Inc.

Position in TGTX — Tg Therapeutics, Inc.

CIK 1595855 Boston, MA
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$29,392,900
+$11,620,200 QoQ
Shares Held
535,000
0.0% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#35
of 426 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. TGTX ranks #7 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IRON
Disc Medicine, Inc.
 855,000 $62,534,700
2 URGN
UroGen Pharma Ltd.
 1,439,996 $52,991,852
3 APGE
Apogee Therapeutics, Inc.
 390,000 $51,764,700
4 MGTX
MeiraGTx Holdings plc
 3,550,000 $47,960,500
5 SLGL
Sol-Gel Technologies Ltd.
 500,000 $37,070,000
6 RZLT
Rezolute, Inc.
 6,300,000 $32,760,000
7 TGTX
Tg Therapeutics, Inc.
This page 		535,000 $29,392,900
8 IMMX
Immix Biopharma, Inc.
 2,345,000 $24,176,950

All Filings in TGTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,392,900 535,000
2026-03-31 $17,772,700 535,000
2025-12-31 $15,948,350 535,000
2025-09-30 $19,326,875 535,000
2025-06-30 $19,254,650 535,000
2025-03-31 $21,095,050 535,000
2024-12-31 $68,026,000 2,260,000
2024-09-30 $53,329,200 2,280,000
2024-06-30 $40,561,200 2,280,000
2024-03-31 $34,678,800 2,280,000
2023-12-31 $37,832,200 2,215,000
2023-09-30 $15,800,400 1,890,000
2020-12-31 $20,157,750 387,500
2020-09-30 $10,436,400 390,000
2020-06-30 $8,894,568 456,600
2020-03-31 $4,851,120 493,000